Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Health and Happiness (H&H) International Holdings ( (HK:1112) ) has issued an announcement.
Health and Happiness (H&H) International Holdings Limited reported a mid-single-digit increase in total revenue for the first half of 2025, driven by growth across all business segments. The Adult Nutrition and Care segment saw significant growth in mainland China and other markets, while the Baby Nutrition and Care segment experienced a resurgence in infant milk formula sales. Despite challenges in the pediatric probiotic sector, the Pet Nutrition and Care segment benefited from trends in pet nutrition and humanization. The company’s strategic focus on e-commerce and market expansion has bolstered its industry position.
The most recent analyst rating on (HK:1112) stock is a Buy with a HK$13.10 price target. To see the full list of analyst forecasts on Health and Happiness (H&H) International Holdings stock, see the HK:1112 Stock Forecast page.
More about Health and Happiness (H&H) International Holdings
Health and Happiness (H&H) International Holdings Limited operates in the health and wellness industry, focusing on adult, baby, and pet nutrition and care. The company is known for its innovative products like Swisse Plus+ and Biostime, with a strong presence in e-commerce and a significant market share in mainland China.
Average Trading Volume: 5,197,045
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.63B
For a thorough assessment of 1112 stock, go to TipRanks’ Stock Analysis page.